ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 962,78
-0,75%
Dow Jones
37 775,38
0,06%
DAX
17 655,01
-1,10%
Brent Oil
87,195
0,90%
Bitcoin
64 615,68
1,74%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Abbott Laboratories (ABT)

  7. Abbott Laboratories (ABT) Actualités

ABT Abbott Laboratories

105,27
0,00 (0,00%)
19 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Abbott Laboratories ABT NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 105,27 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
105,27
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
17/4/202417:37IHMARKETNEWSAbbott Laboratories Reports Strong Q1 Sales Growth Amid..
17/4/202413:30PRNUSAbbott Reports First-Quarter 2024 Results and Raises..
17/4/202412:59IHMARKETNEWSUS Index Futures See Gains, Oil Prices Dip
03/4/202413:12IHMARKETNEWSCal-Maine Surges on Strong Quarterly Performance, Taiwan..
02/4/202415:00PRNUSAbbott Receives FDA Approval for TriClip™, First-of-Its-Kind..
01/4/202415:00PRNUSAbbott Receives FDA Clearance for Whole Blood Rapid Test to..
27/3/202421:30PRNUSAbbott Hosts Conference Call for First-Quarter Earnings
19/3/202413:00PRNCACanadian First - Abbott Advances Chronic Pain Management..
06/3/202415:00PRNUSReal-World Data Show Abbott's FreeStyle Libre® Systems and..
05/3/202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:53EDGAR2Form 144 - Report of proposed sale of securities
01/3/202423:45EDGAR2Form 144 - Report of proposed sale of securities
01/3/202423:39EDGAR2Form 144 - Report of proposed sale of securities
01/3/202423:32EDGAR2Form 144 - Report of proposed sale of securities
01/3/202423:25EDGAR2Form 144 - Report of proposed sale of securities
01/3/202423:22EDGAR2Form 144 - Report of proposed sale of securities
28/2/202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:02EDGAR2Form 144 - Report of proposed sale of securities
16/2/202422:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
16/2/202416:19PRNUSAbbott Declares 401st Consecutive Quarterly Dividend
14/2/202400:47PRNUSFDA Advisory Committee Votes in Favor of Abbott's..
13/2/202422:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/2/202411:31IHMARKETNEWSSantander’s Stock Declines Amid Sanctions Evasion Scandal,..
01/2/202415:00PRNUSNew Study Shows Mixed Reality Technology for Blood Donation..
31/1/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202415:00PRNUSAbbott Launches New PROTALITY™ Brand to Support Adults on..
29/1/202422:10EDGAR2Form 8-K - Current report
29/1/202422:04EDGAR2Form 144 - Report of proposed sale of securities
26/1/202417:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
25/1/202415:00PRNUSAbbott Launches World's Smallest Rechargeable System With..
25/1/202412:25IHMARKETNEWSWall Street Highlights: Nokia’s Margins Surprise, FAA Halts..

Dernières Valeurs Consultées

NYSE
ABT
Abbott Laboratories
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés